Global Home Infusion Therapy research

Home Infusion Therapy Comprehensive Study by Type (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others) Players and Region - Global Market Outlook to 2030

Home Infusion Therapy Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.58%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Home infusion therapy refers to the method within which patients receive treatment reception through the administration of medication or biological products through catheters and needles. Receiving treatment reception as critical hospitals or aid facilities could be a cost-efficient and a lot of convenient choice for patients, more driving the requirement for home infusion medical aid.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledCVS/Coram (United States), Option Care Health (United States), BriovaRx/Diplomat (UnitedHealth Optum) (United States), PharMerica (United States), Fresenius Kabi (Germany), ICU Medical, Inc. (United States), B. Braun Melsungen AG (Germany), Baxter (United States), BD (United States) and Caesarea Medical Electronics (Israel)


According to AMA, the market for Home Infusion Therapy is expected to register a CAGR of 7.58% during the forecast period to 2030. This growth is primarily driven by Rising Preference for Home Care and Rapid Technological Advancements and Rise in Old Age Population and Unhealthy Lifestyle.

Globally, a noticeable market trend is evident Developing Mobility Solutions on Wheel with Various Equipment Major Players, such as CVS/Coram (United States), Option Care Health (United States), BriovaRx/Diplomat (UnitedHealth Optum) (United States), PharMerica (United States), Fresenius Kabi (Germany), ICU Medical, Inc. (United States), B. Braun Melsungen AG (Germany), Baxter (United States), BD (United States) and Caesarea Medical Electronics (Israel), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. This competitive landscape is constantly evolving. Staying ahead of the curve with innovative products, ethical practices, and a strong brand identity is key to success in the green tea powder market.

Key Developments in the Market:
In 2020, Option Care Enterprises, Inc. and BioScrip, Inc. Completed Merger. This merger will create an infusion care experience with full potential of high-quality care in a lower cost setting on a wider scale.
In May 2021, Smiths Medical and Ivenix, Inc. declared an organization consent to offer an extensive set-up of mixture the board arrangements in the U.S. market. This association is supposed to develop mixture the board to work on persistent security.

Regulatory Insights:
Section 5012 of the 21st Century Cures Act and sections 1861(s)(2) and 1861(iii) of the Act is enacted for coverage of home infusion therapy-associated professional services for certain drugs and biologicals administered, or subcutaneously through a pump that is an item of DME.

Influencing Trend:
Developing Mobility Solutions on Wheel with Various Equipment

Market Growth Drivers:
Rising Preference for Home Care and Rapid Technological Advancements and Rise in Old Age Population and Unhealthy Lifestyle

Challenges:
Periodic Medicare Reimbursement of the Equipment and Risks Associated with Irregular Functioning of Infusion Devices

Restraints:
High Cost of Equipment and Maintenance

Opportunities:
Cost Effective Home Infusion Therapy for Cancer, Immune Diseases and Heart Conditions with Different Smart Devices

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Home Infusion Therapy Market
- Analysis about New Entrants in Home Infusion Therapy Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Home Infusion Therapy Study Sheds Light on
— The Home Infusion Therapy Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Home Infusion Therapy industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Home Infusion Therapy industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
By Application
  • Anti-infective
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Preference for Home Care and Rapid Technological Advancements
      • 3.2.2. Rise in Old Age Population and Unhealthy Lifestyle
    • 3.3. Market Challenges
      • 3.3.1. Periodic Medicare Reimbursement of the Equipment
      • 3.3.2. Risks Associated with Irregular Functioning of Infusion Devices
    • 3.4. Market Trends
      • 3.4.1. Developing Mobility Solutions on Wheel with Various Equipment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Home Infusion Therapy, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Home Infusion Therapy (Value)
      • 5.2.1. Global Home Infusion Therapy by: Type (Value)
        • 5.2.1.1. Infusion Pumps
        • 5.2.1.2. Intravenous Sets
        • 5.2.1.3. IV Cannulas
        • 5.2.1.4. Needleless Connectors
      • 5.2.2. Global Home Infusion Therapy by: Application (Value)
        • 5.2.2.1. Anti-infective
        • 5.2.2.2. Hydration Therapy
        • 5.2.2.3. Chemotherapy
        • 5.2.2.4. Enteral Nutrition
        • 5.2.2.5. Parenteral Nutrition
        • 5.2.2.6. Specialty Pharmaceuticals
        • 5.2.2.7. Others
      • 5.2.3. Global Home Infusion Therapy Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Home Infusion Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CVS/Coram (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Option Care Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BriovaRx/Diplomat (UnitedHealth Optum) (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PharMerica (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fresenius Kabi (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ICU Medical, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. B. Braun Melsungen AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Baxter (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BD (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Caesarea Medical Electronics (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Home Infusion Therapy Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Home Infusion Therapy (Value)
      • 7.2.1. Global Home Infusion Therapy by: Type (Value)
        • 7.2.1.1. Infusion Pumps
        • 7.2.1.2. Intravenous Sets
        • 7.2.1.3. IV Cannulas
        • 7.2.1.4. Needleless Connectors
      • 7.2.2. Global Home Infusion Therapy by: Application (Value)
        • 7.2.2.1. Anti-infective
        • 7.2.2.2. Hydration Therapy
        • 7.2.2.3. Chemotherapy
        • 7.2.2.4. Enteral Nutrition
        • 7.2.2.5. Parenteral Nutrition
        • 7.2.2.6. Specialty Pharmaceuticals
        • 7.2.2.7. Others
      • 7.2.3. Global Home Infusion Therapy Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Home Infusion Therapy: by Type(USD Million)
  • Table 2. Home Infusion Therapy Infusion Pumps , by Region USD Million (2018-2023)
  • Table 3. Home Infusion Therapy Intravenous Sets , by Region USD Million (2018-2023)
  • Table 4. Home Infusion Therapy IV Cannulas , by Region USD Million (2018-2023)
  • Table 5. Home Infusion Therapy Needleless Connectors , by Region USD Million (2018-2023)
  • Table 6. Home Infusion Therapy: by Application(USD Million)
  • Table 7. Home Infusion Therapy Anti-infective , by Region USD Million (2018-2023)
  • Table 8. Home Infusion Therapy Hydration Therapy , by Region USD Million (2018-2023)
  • Table 9. Home Infusion Therapy Chemotherapy , by Region USD Million (2018-2023)
  • Table 10. Home Infusion Therapy Enteral Nutrition , by Region USD Million (2018-2023)
  • Table 11. Home Infusion Therapy Parenteral Nutrition , by Region USD Million (2018-2023)
  • Table 12. Home Infusion Therapy Specialty Pharmaceuticals , by Region USD Million (2018-2023)
  • Table 13. Home Infusion Therapy Others , by Region USD Million (2018-2023)
  • Table 14. South America Home Infusion Therapy, by Country USD Million (2018-2023)
  • Table 15. South America Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 16. South America Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 17. Brazil Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 18. Brazil Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 19. Argentina Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 20. Argentina Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 21. Rest of South America Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 22. Rest of South America Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 23. Asia Pacific Home Infusion Therapy, by Country USD Million (2018-2023)
  • Table 24. Asia Pacific Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 25. Asia Pacific Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 26. China Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 27. China Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 28. Japan Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 29. Japan Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 30. India Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 31. India Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 32. South Korea Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 33. South Korea Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 34. Taiwan Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 35. Taiwan Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 36. Australia Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 37. Australia Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 38. Rest of Asia-Pacific Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 39. Rest of Asia-Pacific Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 40. Europe Home Infusion Therapy, by Country USD Million (2018-2023)
  • Table 41. Europe Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 42. Europe Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 43. Germany Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 44. Germany Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 45. France Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 46. France Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 47. Italy Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 48. Italy Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 49. United Kingdom Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 50. United Kingdom Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 51. Netherlands Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 52. Netherlands Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 53. Rest of Europe Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 54. Rest of Europe Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 55. MEA Home Infusion Therapy, by Country USD Million (2018-2023)
  • Table 56. MEA Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 57. MEA Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 58. Middle East Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 59. Middle East Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 60. Africa Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 61. Africa Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 62. North America Home Infusion Therapy, by Country USD Million (2018-2023)
  • Table 63. North America Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 64. North America Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 65. United States Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 66. United States Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 67. Canada Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 68. Canada Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 69. Mexico Home Infusion Therapy, by Type USD Million (2018-2023)
  • Table 70. Mexico Home Infusion Therapy, by Application USD Million (2018-2023)
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Home Infusion Therapy: by Type(USD Million)
  • Table 82. Home Infusion Therapy Infusion Pumps , by Region USD Million (2025-2030)
  • Table 83. Home Infusion Therapy Intravenous Sets , by Region USD Million (2025-2030)
  • Table 84. Home Infusion Therapy IV Cannulas , by Region USD Million (2025-2030)
  • Table 85. Home Infusion Therapy Needleless Connectors , by Region USD Million (2025-2030)
  • Table 86. Home Infusion Therapy: by Application(USD Million)
  • Table 87. Home Infusion Therapy Anti-infective , by Region USD Million (2025-2030)
  • Table 88. Home Infusion Therapy Hydration Therapy , by Region USD Million (2025-2030)
  • Table 89. Home Infusion Therapy Chemotherapy , by Region USD Million (2025-2030)
  • Table 90. Home Infusion Therapy Enteral Nutrition , by Region USD Million (2025-2030)
  • Table 91. Home Infusion Therapy Parenteral Nutrition , by Region USD Million (2025-2030)
  • Table 92. Home Infusion Therapy Specialty Pharmaceuticals , by Region USD Million (2025-2030)
  • Table 93. Home Infusion Therapy Others , by Region USD Million (2025-2030)
  • Table 94. South America Home Infusion Therapy, by Country USD Million (2025-2030)
  • Table 95. South America Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 96. South America Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 97. Brazil Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 98. Brazil Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 99. Argentina Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 100. Argentina Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 101. Rest of South America Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 102. Rest of South America Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 103. Asia Pacific Home Infusion Therapy, by Country USD Million (2025-2030)
  • Table 104. Asia Pacific Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 105. Asia Pacific Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 106. China Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 107. China Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 108. Japan Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 109. Japan Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 110. India Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 111. India Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 112. South Korea Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 113. South Korea Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 114. Taiwan Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 115. Taiwan Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 116. Australia Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 117. Australia Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 118. Rest of Asia-Pacific Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 119. Rest of Asia-Pacific Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 120. Europe Home Infusion Therapy, by Country USD Million (2025-2030)
  • Table 121. Europe Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 122. Europe Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 123. Germany Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 124. Germany Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 125. France Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 126. France Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 127. Italy Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 128. Italy Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 129. United Kingdom Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 130. United Kingdom Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 131. Netherlands Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 132. Netherlands Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 133. Rest of Europe Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 134. Rest of Europe Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 135. MEA Home Infusion Therapy, by Country USD Million (2025-2030)
  • Table 136. MEA Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 137. MEA Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 138. Middle East Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 139. Middle East Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 140. Africa Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 141. Africa Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 142. North America Home Infusion Therapy, by Country USD Million (2025-2030)
  • Table 143. North America Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 144. North America Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 145. United States Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 146. United States Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 147. Canada Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 148. Canada Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 149. Mexico Home Infusion Therapy, by Type USD Million (2025-2030)
  • Table 150. Mexico Home Infusion Therapy, by Application USD Million (2025-2030)
  • Table 151. Research Programs/Design for This Report
  • Table 152. Key Data Information from Secondary Sources
  • Table 153. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Home Infusion Therapy: by Type USD Million (2018-2023)
  • Figure 5. Global Home Infusion Therapy: by Application USD Million (2018-2023)
  • Figure 6. South America Home Infusion Therapy Share (%), by Country
  • Figure 7. Asia Pacific Home Infusion Therapy Share (%), by Country
  • Figure 8. Europe Home Infusion Therapy Share (%), by Country
  • Figure 9. MEA Home Infusion Therapy Share (%), by Country
  • Figure 10. North America Home Infusion Therapy Share (%), by Country
  • Figure 11. Global Home Infusion Therapy share by Players 2023 (%)
  • Figure 12. Global Home Infusion Therapy share by Players (Top 3) 2023(%)
  • Figure 13. Global Home Infusion Therapy share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. CVS/Coram (United States) Revenue, Net Income and Gross profit
  • Figure 16. CVS/Coram (United States) Revenue: by Geography 2023
  • Figure 17. Option Care Health (United States) Revenue, Net Income and Gross profit
  • Figure 18. Option Care Health (United States) Revenue: by Geography 2023
  • Figure 19. BriovaRx/Diplomat (UnitedHealth Optum) (United States) Revenue, Net Income and Gross profit
  • Figure 20. BriovaRx/Diplomat (UnitedHealth Optum) (United States) Revenue: by Geography 2023
  • Figure 21. PharMerica (United States) Revenue, Net Income and Gross profit
  • Figure 22. PharMerica (United States) Revenue: by Geography 2023
  • Figure 23. Fresenius Kabi (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Fresenius Kabi (Germany) Revenue: by Geography 2023
  • Figure 25. ICU Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. ICU Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. B. Braun Melsungen AG (Germany) Revenue: by Geography 2023
  • Figure 29. Baxter (United States) Revenue, Net Income and Gross profit
  • Figure 30. Baxter (United States) Revenue: by Geography 2023
  • Figure 31. BD (United States) Revenue, Net Income and Gross profit
  • Figure 32. BD (United States) Revenue: by Geography 2023
  • Figure 33. Caesarea Medical Electronics (Israel) Revenue, Net Income and Gross profit
  • Figure 34. Caesarea Medical Electronics (Israel) Revenue: by Geography 2023
  • Figure 35. Global Home Infusion Therapy: by Type USD Million (2025-2030)
  • Figure 36. Global Home Infusion Therapy: by Application USD Million (2025-2030)
  • Figure 37. South America Home Infusion Therapy Share (%), by Country
  • Figure 38. Asia Pacific Home Infusion Therapy Share (%), by Country
  • Figure 39. Europe Home Infusion Therapy Share (%), by Country
  • Figure 40. MEA Home Infusion Therapy Share (%), by Country
  • Figure 41. North America Home Infusion Therapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • CVS/Coram (United States)
  • Option Care Health (United States)
  • BriovaRx/Diplomat (UnitedHealth Optum) (United States)
  • PharMerica (United States)
  • Fresenius Kabi (Germany)
  • ICU Medical, Inc. (United States)
  • B. Braun Melsungen AG (Germany)
  • Baxter (United States)
  • BD (United States)
  • Caesarea Medical Electronics (Israel)
Additional players considered in the study are as follows:
Smith’s Medical (United States) , Terumo Corporation (Japan) , JMS Co. Ltd. (Japan)
Select User Access Type

Key Highlights of Report


Mar 2024 213 Pages 91 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Home Infusion Therapy research Quantitative research analysis
Global Home Infusion Therapy research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Home Infusion Therapy market are CVS/Coram (United States), Option Care Health (United States), BriovaRx/Diplomat (UnitedHealth Optum) (United States), PharMerica (United States), Fresenius Kabi (Germany), ICU Medical, Inc. (United States), B. Braun Melsungen AG (Germany), Baxter (United States), BD (United States) and Caesarea Medical Electronics (Israel), to name a few.
is dominating the Home Infusion Therapy Market.
"Periodic Medicare Reimbursement of the Equipment " is seen as one of the major challenges by many Industry Players of Home Infusion Therapy Market
The Home Infusion Therapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Home Infusion Therapy market is expected to see a steady growth rate during projected year 2023 to 2030.

Know More About Global Home Infusion Therapy research Report?

Have a Query? Click Here

Other Related Reports

Diphtheria Vaccine Comprehensive Study by Type (DTaP, DT, Td, Tdap), Application (Childrens, Adolescents and Adults), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook ...
$ 3500
Panic Disorders Comprehensive Study by Type (Anxiety Disorders, Generalized Anxiety Disorder, Obsessive-Compulsive Disorder), Application (Hospitals, Specialty Clinics, Home Care, Others), Drug Type ...
$ 3650
Clear Aligners Comprehensive Study by Type (Advanced, Ordinary), Application (Adults, Teenagers), Distribution Chanel (Direct Sale, Laboratories, Other) Players and Region - Global Market Outlook to ...
$ 3500
Plasma Protein Therapeutics Comprehensive Study by Type (Immunoglobulin, Albumin, Plasma-derived factor VIII, Plasma Proteins, Globulins, Fibrinogen), Application (Hemophilia, Idiopathic thrombocytop...
$ 3800
Oral Anticoagulant Comprehensive Study by Type (Warfarin, Dabigatran, Rivaroxaban, Others), Application (Thromboembolic Disease, Disseminated Intravascular Coagulation, Cardiovascular Surgery, Others...
$ 3450
Primary Cells Comprehensive Study by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Researc...
$ 3350